Harvard Business Review

APRIL 22, 2013

Most of us think of biotech as the province of multinational pharmaceutical corporations and well-funded ventures, but the founders of BioCurious believe (as they say in their mission statement) "that innovations in biology should be accessible, affordable, and open to everyone." No large-scale manufacturing facility required.

Biotech 13

Biotech Assets Scaling Software 13

Harvard Business Review

AUGUST 6, 2015

It’s hard to predict whether a novel idea will succeed, and these fledgling firms typically have no financial track record or tangible assets. Maybe later on, when the company is on track and growing to a larger scale, the founder becomes less important,” Bernstein said. ”

Biotech 14

Biotech Assets Scaling Media 14

Harvard Business Review

SEPTEMBER 14, 2011

In doing so, Dr Reddy's strengthens its core generic drugs business and boosts the custom manufacturing services it provides to Big Pharma and nimble biotech startups. Moreover, Western and Eastern firms come to this battle with different assets and backgrounds. Eastern firms excel at more frugal and flexible forms of innovation.

Biotech 12

Biotech Engineering Marketing Operations 12